Company CVAbout Aarti Pharmalabs Ltd 
Aarti Pharmalabs Ltd
Small Cap
Pharmaceuticals & Biotechnology
Aarti Pharmachem Limited, formerly known as Aarti Organics Limited, was incorporated as a Public Limited Company in 2019. The Company changed the name from Aarti Organics Limited to Aarti Pharmachem Limited on July 1, 2021. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 45.31 Cr
Number of Shares
9.06 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
21-Oct-2022
9.06
45.31
90626008
5
Scheme of arrangement - Demerger
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
0.0077
Mutual Funds
Held by 7 Schemes (0.79%)
FIIs
Held by 116 FIIs (8.02%)
Promoter with highest holding
Rashesh Chandrakant Gogri (4.23%)
Highest Public shareholder
Life Insurance Corporation Of India (5.28%)
Individual Investors Holdings
35.39%
Board of Directors
Management
Designation
Remuneration
Rashesh C Gogri
Chairman
72.0 k
Hetal Gogri Gala
Vice Chairperson & MD
7.05 cr
Narendra Jagannath Salvi
Managing Director
1.71 cr
Rajendra V Gogri
Non-Exec & Non-Independent Dir
54.0 k
Parimal H Desai
Non Executive Director
54.0 k
Bhavesh R Vora
Independent Director
81.0 k
Vinay Gopal Nayak
Independent Director
90.0 k
Vilas G Gaikar
Independent Director
81.0 k
Jeenal Savla
Independent Director
99.0 k
Rupal Vora
Independent Director
63.0 k
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
418 Cr
(Quarterly Results - Sep 2025)
Net Profit:
28 Cr
Pharmaceuticals & Biotechnology
INR 6,526 Cr (Small Cap)
27.00
34
0.69%
0.29
11.72%
3.19
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
